{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:03:28Z","timestamp":1792803808880,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013262","name":"Institute of Research Management and Innovation, Universiti Teknologi MARA","doi-asserted-by":"publisher","award":["LESTARI UiTM Research Grant: 600-IRMI\/Myra 5\/3\/LESTARI (038\/2017)"],"award-info":[{"award-number":["LESTARI UiTM Research Grant: 600-IRMI\/Myra 5\/3\/LESTARI (038\/2017)"]}],"id":[{"id":"10.13039\/501100013262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Non-alcoholic fatty liver disease (NAFLD) is an emerging novel cardiovascular disease (CVD) risk factor. It\u2019s prevalence is increasing globally. However, there is paucity in the evidence showing the association between NAFLD and CVD risk in primary care setting. Therefore, the objectives of this study were to determine the prevalence and factors associated with NAFLD among patients with \u22651 risk factor for NAFLD or CVD attending primary care clinics.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methodology<\/jats:title>\n<jats:p>A cross sectional study was conducted in two clinics at a university primary care centre. Patients aged \u226518\u2009years with \u22651 risk factor for NAFLD or CVD were recruited. Participants with history of established liver disease or chronic alcohol use were excluded. Socio-demographics, clinical related data, anthropometric measurements and blood investigation results were recorded in a proforma. Diagnosis of NAFLD was made using abdominal ultrasound. The 10-year CVD risk was calculated using the general Framingham Risk Score (FRS). Multiple logistic regression (MLogR) was performed to identify independent factors associated with NAFLD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 263 participants were recruited. The mean age was 52.3\u2009\u00b1\u200914.7\u2009years old. Male and female were equally distributed. Majority of the participants were Malays (79.8%). The overall prevalence of NAFLD was 54.4% (95%CI 48,60%). Participants in the high FRS category have higher prevalence of NAFLD (65.5%), followed by those in the moderate category (55.4%) and the low category (46.3%), <jats:italic>p<\/jats:italic>\u2009=\u20090.025. From MLogR, independent factors associated with NAFLD were being employed (OR\u2009=\u20092.44, 95%CI 1.26,4.70, <jats:italic>p<\/jats:italic>\u2009=\u20090.008), obesity with BMI \u226527.5 (OR\u2009=\u20092.89, 95%CI 1.21,6.91, <jats:italic>p<\/jats:italic>\u2009=\u20090.017), elevated fasting glucose \u22655.6\u2009mmol\/L (OR\u2009=\u20092.79, 95%CI 1.44,5.43, <jats:italic>p<\/jats:italic>\u2009=\u20090.002), ALT \u226534\u2009U\/L (OR\u2009=\u20093.70, 95%CI 1.85,7.44, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and high FRS category (OR\u2009=\u20092.82, 95%CI 1.28,6.23, <jats:italic>p<\/jats:italic>\u2009=\u20090.010).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>NAFLD is highly prevalent among patients with \u22651 risk factor for NAFLD or CVD in these primary care clinics. Patients who were obese, have elevated fasting glucose, elevated ALT and in the high FRS category were more likely to have NAFLD. This study underscores the importance of targeted screening for NAFLD in those with risk factors in primary care. Aggressive intervention must be executed in those with NAFLD in order to reduce CVD complications and risk of progression.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12875-020-01306-7","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T16:03:48Z","timestamp":1605888228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?"],"prefix":"10.1186","volume":"21","author":[{"given":"Hayatul Najaa","family":"Miptah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-1413","authenticated-orcid":false,"given":"Anis Safura","family":"Ramli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilwati","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahirah","family":"Tharek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"issue":"6","key":"1306_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","volume":"48","author":"DR Labrecque","year":"2014","unstructured":"Labrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, et al. World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitisbrecq. J Clin Gastroenterol. 2014;48(6):467\u201373.","journal-title":"J Clin Gastroenterol"},{"key":"1306_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.pop.2017.07.003","volume":"44","author":"PH Sweet","year":"2017","unstructured":"Sweet PH, Khoo T, Nguyen S. Nonalcoholic fatty liver disease. Prim Care. 2017;44:599\u2013607.","journal-title":"Prim Care"},{"issue":"1","key":"1306_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology."},{"issue":"4","key":"1306_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cld.716","volume":"11","author":"E Cleveland","year":"2018","unstructured":"Cleveland E, Bandy A, VanWagner LB. Diagnostic challenges of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Clin Liver Dis. 2018;11(4):98\u2013104.","journal-title":"Clin Liver Dis"},{"key":"1306_CR5","volume-title":"Non-alcoholic fatty liver disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Primary care diabetes","author":"MH Ahmed","year":"2010","unstructured":"Ahmed MH, Abu EO, Byrne CD. Non-alcoholic fatty liver disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Primary care diabetes; 2010."},{"issue":"2","key":"1306_CR6","first-page":"51","volume":"8","author":"R Patil","year":"2017","unstructured":"Patil R, Sood GK. Nonalcoholic fatty liver disease and cardiovascular risk. Curr Gastroenterol Rep. 2017;8(2):51\u20138.","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"1306_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1478-3231.2011.02753.x","volume":"32","author":"S Treeprasertsuk","year":"2012","unstructured":"Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int. 2012;32(6):945\u2013050.","journal-title":"Liver Int"},{"key":"1306_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","volume":"41","author":"N Motamed","year":"2017","unstructured":"Motamed N, Rabiee B, Poustchi H, Dehestani B, Hemasi GR, Khonsari MR, et al. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clin Res Hepatol Gastroenterol. 2017;41:31\u20138.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4254\/wjh.v10.i7.474","volume":"10","author":"S Alkagiet","year":"2018","unstructured":"Alkagiet S, Papagiannis A, Tziomalos K. World journal of Hepatolgy. World J Hepatol. 2018;10(7):474\u20138.","journal-title":"World J Hepatol"},{"issue":"3","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C, BCh M. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis of observational studies. J Hepatol. 2016;65(3):1\u201329. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.013.","journal-title":"J Hepatol"},{"issue":"8","key":"1306_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","volume":"40","author":"CH Chen","year":"2006","unstructured":"Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745\u201352.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1306_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0019-557X.177295","volume":"60","author":"A Majumdar","year":"2016","unstructured":"Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav C. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016;60(1):26\u201333 http:\/\/www.ijph.in\/text.asp?2016\/60\/1\/26\/177295.","journal-title":"Indian J Public Health"},{"issue":"7","key":"1306_CR13","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.1440-1746.2009.05831.x","volume":"24","author":"AS Dassanayake","year":"2009","unstructured":"Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24(7):1284\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12072-012-9359-2","volume":"7","author":"SC Goh","year":"2013","unstructured":"Goh SC, Ho ELM, Goh KL. Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. Hepatol Int. 2013;7(2):548\u201354.","journal-title":"Hepatol Int"},{"issue":"8","key":"1306_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/jgh.12204","volume":"28","author":"WK Chan","year":"2013","unstructured":"Chan WK, Tan ATB, Vethakkan SR, Tah PC, Vijayananthan A, Goh KL. Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. J Gastroenterol Hepatol. 2013;28(8):1375\u201383.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1306_CR16","first-page":"936","volume":"41","author":"E Magosso","year":"2010","unstructured":"Magosso E, Ansari MA, Gopalan Y, Bakar MRA, Khan NAK, Wong JW, et al. Prevalence of non-alcoholic fatty liver in a hypercholesterolemic population of northwestern peninsular Malaysia. Southeast Asian J Trop Med Public Health. 2010;41(4):936\u201342.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"1306_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jceh.2015.09.001","volume":"5","author":"SP Singh","year":"2015","unstructured":"Singh SP, Singh A, Misra D, Misra B, Pati GK, Panigrahi MK, et al. Risk factors associated with non-alcoholic fatty liver disease in Indians: a case-control study. J Clin Exp Hepatol. 2015;5(4):295\u2013302.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"1306_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","volume":"22","author":"L Caballer\u00eda","year":"2010","unstructured":"Caballer\u00eda L, Pera G, Auladell MA, Tor\u00e1n P, Mu\u00f1oz L, Miranda D, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol [Internet]. 2010;22(1):24\u201332 Available from: http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00042737-201001000-00004.","journal-title":"Eur J Gastroenterol Hepatol [Internet]"},{"issue":"6","key":"1306_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1148\/rg.266065004","volume":"26","author":"OW Hamer","year":"2006","unstructured":"Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB. Fatty liver: imaging patterns and pitfalls. RadioGraphics. 2006;26(6):1637\u201353. https:\/\/doi.org\/10.1148\/rg.266065004.","journal-title":"RadioGraphics"},{"key":"1306_CR20","unstructured":"Framingham Heart Study. Hard coronary heart disease (10-year risk). JAMA. 2001; [cited 2019 Jan 29]. Available from: https:\/\/www.framinghamheartstudy.org\/fhs-risk-functions\/hard-coronary-heart-disease-10-year-risk\/."},{"issue":"5","key":"1306_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2014-007324","volume":"5","author":"YC Chia","year":"2015","unstructured":"Chia YC, Gray SYW, Ching SM, Lim HM, Chinna K. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open. 2015;5(5):1\u20137.","journal-title":"BMJ Open"},{"issue":"1","key":"1306_CR22","first-page":"9","volume":"12","author":"S Suppiah","year":"2016","unstructured":"Suppiah S, Chow LRM, Sazali NSB, Hassan HA. Non-alcoholic fatty liver disease in metabolic syndrome patients in Serdang hospital: quantification by contrast-enhanced computed tomography. Malaysian J Med Heal Sci. 2016;12(1):9\u201318.","journal-title":"Malaysian J Med Heal Sci"},{"issue":"July","key":"1306_CR23","first-page":"448","volume":"61","author":"S Kalra","year":"2013","unstructured":"Kalra S, Vithalani M, Gulati G. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India [Internet]. 2013;61(July):448\u201353 Available from: http:\/\/www.cdc.qc.ca\/parea\/786320_boisvert_st_jean_sur_richelieu_reussite_garcons_parea_2006.pdf.","journal-title":"J Assoc Physicians India [Internet]"},{"issue":"1","key":"1306_CR24","first-page":"S1","volume":"10","author":"NAD Atan","year":"2017","unstructured":"Atan NAD, Koushki M, Motedayen M, Dousti M, Sayehmiri F, Vafaee R, et al. Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterol Hepatol from Bed to Bench. 2017;10(1):S1\u20137.","journal-title":"Gastroenterol Hepatol from Bed to Bench"},{"issue":"1","key":"1306_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","volume":"29","author":"NC Leite","year":"2009","unstructured":"Leite NC, Salles GF, Araujo ALE, Villela-Nogueira CA, Cardoso CRL. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 2009;29(1):113\u20139.","journal-title":"Liver Int"},{"key":"1306_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.12417.1","volume":"6","author":"U Summart","year":"2017","unstructured":"Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS. Gender differences in the prevalence of nonalcoholic fatty liver disease in the northeast of Thailand: a population-based cross-sectional study. F1000Research. 2017;6:1\u201317.","journal-title":"F1000Research"},{"issue":"6","key":"1306_CR27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"J Browning","year":"2004","unstructured":"Browning J, Szczepaniak L, Dobbins R, Nuremberg P, Horton J, Cohen J, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387\u201395.","journal-title":"Hepatology."},{"issue":"1","key":"1306_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology. 2005;42(1):44\u201352.","journal-title":"Hepatology."},{"key":"1306_CR29","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/ajg.2009.238","volume":"104","author":"S-Y Choi","year":"2009","unstructured":"Choi S-Y, Kim D, Kim H-J. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol. 2009;104:1953\u201360 Available from: www.amjgastro.com.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1306_CR30","first-page":"903","volume":"30","author":"P Xueqin","year":"2014","unstructured":"Xueqin P, Weichang C, Huang F. Risk factors for non-alcoholic fatty liver disease: a multivariate analysis. J Clin Hepatol. 2014;30(9):903\u20135.","journal-title":"J Clin Hepatol"},{"issue":"46","key":"1306_CR31","first-page":"1","volume":"95","author":"C Li","year":"2016","unstructured":"Li C, Xing J-J, Shan A-Q, Leng L, Liu J-C, Yue S, et al. Increased risk of nonalcoholic fatty liver disease with occupational stress in Chinese policemen: a 4-year cohort study. Med Int. 2016;95(46):1\u20138 Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=ovftr&NEWS=N&AN=00005792-201611150-00037.","journal-title":"Med Int"},{"issue":"3","key":"1306_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","volume":"43","author":"JG Fan","year":"2005","unstructured":"Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43(3):508\u201314.","journal-title":"J Hepatol"},{"issue":"2","key":"1306_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic and clinical implications NIH public access. Hepatology. 2010;51(2):679\u201389.","journal-title":"Hepatology."},{"issue":"e019974","key":"1306_CR34","first-page":"1","volume":"8","author":"X-Y Hu","year":"2018","unstructured":"Hu X-Y, Li Y, Li L-Q, Zheng Y, Lv J-H, Huang S-C, et al. Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ Open. 2018;8(e019974):1\u20137 Available from: http:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-019974.","journal-title":"BMJ Open"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-020-01306-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12875-020-01306-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-020-01306-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T16:05:14Z","timestamp":1605888314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-020-01306-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1186\/s12875-020-01306-7","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, the code of ethics of the World Medical Association. Ethical approval was obtained from the university Research Ethics Committee, Research Management Institute [600-IRMI (5\/1\/16)\/REC\/170\/17]. Patient information leaflets were distributed in Malay and English language. Written informed consent was obtained from the participants before they were recruited into the study. Participants were informed that they could withdraw from the study at any time if they wish to do so.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants\u2019 consent for publication is not applicable as participants\u2019 individual data was neither provided nor presented in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}